269 related articles for article (PubMed ID: 11872641)
1. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer.
Cavalieri EL; Devanesan P; Bosland MC; Badawi AF; Rogan EG
Carcinogenesis; 2002 Feb; 23(2):329-33. PubMed ID: 11872641
[TBL] [Abstract][Full Text] [Related]
2. Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes.
Cao K; Devanesan PD; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1998 Aug; 11(8):917-24. PubMed ID: 9705754
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.
Cavalieri EL; Kumar S; Todorovic R; Higginbotham S; Badawi AF; Rogan EG
Chem Res Toxicol; 2001 Aug; 14(8):1041-50. PubMed ID: 11511178
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
5. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
[TBL] [Abstract][Full Text] [Related]
6. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
7. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
8. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
10. Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells.
Mosli HA; Tolba MF; Al-Abd AM; Abdel-Naim AB
Toxicol Lett; 2013 Jul; 220(3):247-58. PubMed ID: 23685341
[TBL] [Abstract][Full Text] [Related]
11. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer.
Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191
[TBL] [Abstract][Full Text] [Related]
12. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
13. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
14. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
Lane KE; Ricci MJ; Ho SM
Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
[TBL] [Abstract][Full Text] [Related]
16. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
Garner CE; Burka LT; Etheridge AE; Matthews HB
Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
[TBL] [Abstract][Full Text] [Related]
17. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.
Cao K; Stack DE; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1998 Aug; 11(8):909-16. PubMed ID: 9705753
[TBL] [Abstract][Full Text] [Related]
19. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
Cavalieri EL; Stack DE; Devanesan PD; Todorovic R; Dwivedy I; Higginbotham S; Johansson SL; Patil KD; Gross ML; Gooden JK; Ramanathan R; Cerny RL; Rogan EG
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10937-42. PubMed ID: 9380738
[TBL] [Abstract][Full Text] [Related]
20. Differences in 4-hydroxyestradiol levels in leukocytes are related to CYP1A1(∗)2C, CYP1B1(∗)3 and COMT Val158Met allelic variants.
Martínez-Ramírez OC; Pérez-Morales R; Petrosyan P; Castro-Hernández C; Gonsebatt ME; Rubio J
Steroids; 2015 Oct; 102():1-6. PubMed ID: 26123186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
